Management of Newer Antidepressant Medications in U.S. Commercial Health Plans. [electronic resource]
- The journal of mental health policy and economics Dec 2015
- 165-73 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1091-4358
Antidepressive Agents--economics Citalopram--economics Cost Control--economics Cost Sharing--economics Desvenlafaxine Succinate--economics Drug Costs--statistics & numerical data Drug Utilization Duloxetine Hydrochloride--economics Fluvoxamine--economics For-Profit Insurance Plans--economics Health Care Surveys Health Services Accessibility--economics Humans Insurance Coverage--economics Insurance, Pharmaceutical Services--economics Preferred Provider Organizations--economics Private Sector--economics Selegiline--economics United States Venlafaxine Hydrochloride--economics